Sign in

You're signed outSign in or to get full access.

Michael Smith

Michael Smith

President and Chief Executive Officer at Lamb Weston HoldingsLamb Weston Holdings
CEO
Executive
Board

About Michael Smith

Michael J. Smith, 48, has served as President and Chief Executive Officer (PEO) of Lamb Weston and as a director since January 3, 2025. He previously was COO (May 2023–Jan 2025) and held senior commercial and strategy roles at Lamb Weston and Conagra; he holds a BA in marketing communications (BYU) and an MBA (SMU) . FY2025 results under his leadership included net sales of $6,451.3 million and Adjusted EBITDA of $1,220.5 million, with AIP paying 0% against targets as both net sales and Adjusted EBITDA missed threshold; the CEO “compensation actually paid” (CAP) was negative for FY2025, and the $100 TSR index stood at $91 vs peer at $113 at fiscal-year end . The Board increased the CEO stock ownership guideline to 600% of base salary and emphasizes at‑risk pay (87% of CEO target pay), with longer-term incentives tied 50% to Adjusted EBITDA growth and 50% to relative TSR .

Past Roles

OrganizationRoleYearsStrategic Impact / Notes
Lamb WestonPresident & CEO; DirectorJan 2025–presentCEO and director appointment as part of planned succession; led “Focus to Win” plan emphasizing savings, execution, and capital discipline .
Lamb WestonChief Operating OfficerMay 2023–Jan 2025Oversaw operations during restructuring to improve utilization and cost structure .
Lamb WestonSVP & GM, Foodservice, Retail, Marketing & InnovationApr 2018–May 2023Led commercial segments and innovation strategy .
Lamb WestonSVP, Growth & StrategySep 2016–Apr 2018Drove corporate strategy post-spin from Conagra .
Lamb Weston RetailVP & GMMay 2011–Sep 2016Led retail P&L and brand/commercial execution .
Conagra (Private Brands)VP & GMMar 2014–Feb 2016Managed Private Brands portfolio (during overlap with LW prior to separation) .
Lamb WestonVP, Global MarketingJul 2012–Mar 2014Oversaw global marketing and customer insights .
Dean Foods / WhiteWaveBrand Management rolesMay 2003–Dec 2007Early career brand leadership in food and beverage .

External Roles

OrganizationRoleYearsNotes
No other current public company directorships disclosed in the proxy .

Fixed Compensation

MetricFY2023FY2024FY2025
Base Salary (paid) ($)675,000 750,000 847,116
Base Salary Rate at FY-end ($)750,000 1,000,000
Target AIP (% of Salary)115% (COO) / 150% (CEO, prorated)
Target AIP ($)1,110,144
Actual AIP Payout ($)1,350,000 0 0
Stock Awards Grant-Date Fair Value ($)2,699,865 1,985,092 1,764,006
All Other Compensation ($)147,886 487,839 77,494
Total ($)6,222,737 3,222,931 2,688,616

Notes:

  • FY2025 AIP metrics (50% net sales, 50% Adjusted EBITDA) paid 0% as both results were below threshold .

Performance Compensation

Annual Incentive Plan (AIP) – FY2025

MetricWeightThreshold (25% payout)Target (100%)Maximum (200%)ResultPayout
Net Sales ($mm)50% 6,650 7,000 7,350 6,451 0%
Adjusted EBITDA ($mm)50% 1,348 1,465 1,612 1,221 0%

Design and adjustments: pre-determined adjustments to isolate underlying performance; no adjustments were made to FY2025 AIP awards .

Long-Term Incentive Plan (LTIP)

  • Mix and vesting: 60% PSAs (3-year performance), 40% RSUs (3-year ratable vesting); PSAs measured 50% on relative TSR and 50% on Adjusted EBITDA growth .
  • FY2025 CEO target pay mix at appointment: At-risk 87% (AIP 19%, RSUs 28%, PSAs 40%) .
  • Timing: Annual grants approved in July, post-10-K; no options granted around earnings or MNPI windows .

PSA Outcomes (most recent completed cycle):

PSA CycleMetricsOutcomeNotes
FY2023–FY202550% Relative TSR; 50% Adjusted EBITDA AAGRCombined payout 116.7% of target; TSR at 64th percentile paid 100%; EBITDA AAGR component paid 133.3% .Standard three-year performance period and certification .
In-Flight (FY2024–FY2026; FY2025–FY2027)Same metricsYear 2 (2024–2026) and Year 1 (2025–2027) EBITDA tranches not earned for FY2025 period; TSR tranches continue per plan .Pro-rata/target vesting rules on death/disability/retirement per plan .

Option/RSU treatment on separation and CoC: double-trigger vesting for options and RSUs upon CoC and qualifying termination; detailed pro-rata and accelerated vesting by scenario set in plan documents .

Equity Ownership & Alignment

Ownership ItemAmount
Beneficially Owned Shares110,553 shares
Deferred/Additional Units53,171 units
Total Shares/Interests Held163,724
Options Exercisable within 60 Days52,123
Unvested RSUs (by grant)2,403 (2022), 5,083 (2023), 13,459 (2024); total 20,945
Unearned PSAs (by grant)8,850 (2022), 11,350 (2023), 20,186 (2024); total 40,386
Shares PledgedNone; pledging/hedging prohibited
Stock Ownership Guideline (CEO)600% of base salary; 75% net-share retention until met

Note: Individual directors and executive officers each own <1% of shares outstanding; LW had 139,354,724 shares outstanding as of Aug 1, 2025 .

Vesting and realized equity (FY2025): 23,511 shares vested for Smith (value realized $1,324,847); no options exercised .

Deferred compensation (FY2025): Executive contributions $48,600; registrant contributions $36,450; aggregate balance $1,171,003; no above‑market earnings .

Employment Terms

  • Employment status: U.S. executive officers are employed “at will”; no individual employment contracts or severance agreements; compensation plans include risk mitigators and clawbacks .
  • Clawbacks: Dodd‑Frank Rule 10D‑1 recoupment plus broader legacy clawback for detrimental conduct .
  • Hedging/pledging: Prohibited for directors and executive officers .

Change-of-Control (COC) Plan (double trigger):

  • Tier I (Smith) benefits upon CoC + qualifying termination: 3x (base salary + higher of target bonus or highest of prior 3‑year actual), pro‑rated AIP for year of termination, COBRA differential for 36 months, full acceleration of service‑based equity, and performance awards at target or actual if determinable .

Potential payments if terminated at FY2025 year-end assumptions:

Scenario (as of May 25, 2025)Cash Severance ($)Accelerated Equity ($)Health/Other ($)Total ($)
Early Retirement / Invol. Termination w/o Cause or Vol. w/ Good Reason
Death3,101,098 1,000,000 4,101,098
Disability2,724,815 150,000 2,874,815
CoC + Invol. Termination w/o Cause or Vol. w/ Good Reason8,160,145 3,190,454 94,143 11,444,742

Board Governance (Director Service, Committees, Independence)

  • Board service: Director since Jan 2025; employee director (not independent) .
  • Committee roles: None (Audit, Compensation, and N&CG committees are fully independent; Smith is not a member) .
  • Board leadership/independence: Independent Chairman (Bradley A. Alford); 12 of 13 directors independent; regular executive sessions without management .
  • Attendance: Board held 14 meetings in FY2025; each director attended at least 75% of meetings in their service period .
  • Director compensation: Employee directors receive no additional director pay; separate stock ownership requirements for non‑employee directors .

Dual-role implications:

  • Concentration risk mitigated by independent chair, majority-independent board, and independent committee structures; Smith’s non‑independent status noted per NYSE rules .

Investment Implications

  • Pay-for-performance alignment: FY2025 AIP paid 0% as both net sales and Adjusted EBITDA were below threshold; PSAs are majority of LTIP with 3‑year horizons; recent PSA cycle paid 116.7%, reflecting TSR at median+ and EBITDA AAGR above target, while in‑flight EBITDA tranches did not earn—suggests balanced but tight calibration and potential variability in realized equity .
  • Retention and selling pressure: 600% CEO ownership guideline and 75% net-share retention until compliant, combined with no pledging/hedging, reduce near‑term selling pressure; meaningful unvested RSUs/PSAs and unexercised options further bind retention .
  • Change-of-control economics: As a Tier I participant, Smith’s double‑trigger COC benefits (3x cash plus equity acceleration and benefits) are market‑standard for size/sector and support objectivity in strategic transactions; at FY2025 marks, potential COC package totaled ~$11.4 million .
  • Governance quality: Independent chair, fully independent key committees, clawbacks, and prohibitions on hedging/pledging mitigate governance risk of CEO-director dual role; employee directors receive no board fees, limiting conflicts .
  • Execution track record: FY2025 was challenged (Adjusted EBITDA $1,220.5m; TSR at $91 vs peer $113), but management initiated restructuring and a cost‑savings plan; H2 FY2025 showed a return to growth with “Focus to Win” actions aimed at FCF and ROIC in future incentives—monitor FY2026 AIP/ROIC metrics and any insider Form 4 activity near vesting dates for signals .